High expression of several candidate genes was strongly associated with lower LC survival in the diagnostic study, and the strongest associations were observed for ANXA3 and ARG1 in prospective late-stage LC cases, especially within two years of LC diagnosis. This evidence concerns the gene ANXA3 and laryngotracheoesophageal cleft.